✦ LIBER ✦

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma

✍ Scribed by Arnold, J M; Huggard, P R; Cummings, M; Ramm, G A; Chenevix-Trench, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pharmacogenetic study of risperidone o

✍ Xiong, Yuyu; Wei, Zhiyun; Huo, Ran; Wu, Xi; Shen, Lu; Li, Yang; Gong, Xueli; Wu, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Up-regulation of chemokine C–C ligand 2

✍ J. C. Santos; C. A. de Brito; E. A. Futata; M. H. Azor; N. M. Orii; C. W. Maruta 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

CDIP-2, a synthetic peptide derived from

✍ E. Mendez-Enriquez; Y. Melendez; F. Martinez; G. Baay; S. Huerta-Yepez; C. Gonza 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Inhibition of the chemokine (C–C motif)

✍ S. J. Yang; H. B. IglayReger; H. C. Kadouh; P. F. Bodary 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 287 KB

Expression of chemokine (C–C motif) liga

✍ Daniel A. Hägg; Fredrik J. Olson; Josefin Kjelldahl; Margareta Jernås; Dag S. Th 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 424 KB

A Novel Activator of C-C Chemokine, FROU

✍ Mamoru Satoh; Tomonari Akatsu; Yuh Ishkawa; Yoshitaka Minami; Motoyuki Nakamura 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 429 KB